This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project
British Journal of Cancer Open Access 12 October 2022
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
20 August 2021
A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01520-9
References
Van Bockstal, M. R. Libbrecht, L. Galanta, C. Comment on: Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project. Br. J. Cancer.
Shaaban, A. M., Hilton, B., Clements, K., Provenzano, E., Cheung, S., Wallis, M. G. et al. Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project. Br. J. Cancer. https://doi.org/10.1038/s41416-020-01152-5 (2020).
Shah, V., Megalios, A., Shami, R., Sridharan, M., Salinas de Souza, C., Kumar, T. et al. Genomic analysis of paired DCIS and subsequent recurrence to assess clonal relatedness in screen detected DCIS [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium. 2019; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P4-07-04.
Sanders, M. E., Schuyler, P. A., Dupont, W. D. & Page, D. L. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103, 2481–2484 (2005).
Stout, N. K., Cronin, A. M., Uno, H., Ozanne, E. M., Hassett, M. J., Frank, E. S. et al. Estrogen-receptor status and risk of contralateral breast cancer following DCIS. Breast Cancer Res. Treatment 171, 777–781 (2018).
Acknowledgements
The Sloane Project uses data provided by patients and collected by the UK NHS BSP as part of their care and support. We thank all patients and all breast units who have participated in the Sloane Project Audit.
Author information
Authors and Affiliations
Contributions
A.M.S.: wrote first draft of the letter. B.H., K.C., S.P. and A.M.H.: reviewed and edited the letter. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethical approval and consent to participate
Ethics Committee approval was not required for this study, originally conducted under the NHS Cancer Screening Programme’s application to the Patient Information Advisory Group (PIAG). More recently, the study has been permitted to process personally identifiable data without consent under Regulation 5 of Statutory Instrument 2002 No. 1438: The Health Service (Control of Patient Information) Regulations 2002 (15/CAG/0207) in line with the following clause: “quality assuring screening services to ensure they are effective and safe, and that any incidents are investigated and managed appropriately”. This statutory exemption to common law permits Public Health England to process personally identifiable data for activities it is ‘responsible and accountable to the Secretary of State for Health for’, as part of its core remit for population screening.
Consent to publish
Not applicable.
Data availability
Data is held by Public Health England. Access to the Sloane Project data from external parties is governed by consultation with the Sloane Project Steering Group and application to Public Health England’s breast screening research advisory committee (RAC) and Public Health England’s office for data release (ODR). Data will subsequently only be released by Public Health England to researchers under approval and in an anonymised or depersonalised format, with a data sharing contract in place.
Competing interests
The authors declare no competing interests.
Funding information
The Sloane Project was supported by Public Health England and, in part, by Cancer Research UK and by KWF Kankerbestrijding (ref. C38317/A24043).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: Due to an Additional Information error.
Rights and permissions
About this article
Cite this article
Shaaban, A.M., Hilton, B., Clements, K. et al. Reply to “Comment on: Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project”. Br J Cancer 124, 1463–1464 (2021). https://doi.org/10.1038/s41416-021-01281-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-021-01281-5